Abstract：Objective To investigate the effect of Coicis Semen oil on intestinal flora and inflammatory factors. Methods According to the random number table method, 75 SPF male Kunming mice were divided into blank control group, model group, low, medium and high dose group, with 15 mice in each group. Lincomycin was gavaged interfered with the intestinal flora of mice for modeling. After modeling, the model group was given 0.33 g/(kg·d) normal saline, while the low, medium and high dose group were given 0.17, 0.33 and 1.00 g/(kg·d) Coicis Semen oil for 30 days by gavage. The difference of colonic histopathological morphology in each group were observed. The number of Enterococcus, Enterobacter, Bifidobacterium and Lactobacillus, and the weight of mice in each group were compared. The levels of interleukin-6 (IL-6), C-C chemokine ligand 2 (CCL2), IL-1α and IL-1β were compared. Results In the blank control group, the pathological morphology of the colon was normal. In the model group, the inflammation of the pathological morphology was serious. In the low, medium and high dose groups, the pathological morphology was gradually improved compared with the model group. The number of Enterococcus and Enterobacter in the colon of mice in model group were higher than those in blank control group, the number of Bifidobacterium and Lactobacillus in model group were lower than those of the blank control group, and the differences were statistically significant (all P < 0.05). The number of Enterococcus and Enterobacter in the colon of mice in low, medium and high dose groups were lower than those in model group, the number of Bifidobacterium and Lactobacillus in low, medium and high dose groups were higher than those in model group, and the differences were statistically significant (all P < 0.05). On the 30th day, the weight of mice in the low, medium and high dose groups were higher than those in model group, and the differences were statistically significant (all P < 0.05). The levels of IL-6, CCL2, IL-1α and IL-1β in model group were higher than those in the blank control group, while the levels of IL-6, CCL2, IL-1α and IL-1β in the low, medium and high dose groups were lower than those in model group, and the differences were statistically significant (all P < 0.05). Conclusion Coicis Semen oil can improve the imbalance of intestinal flora and inhibit the expression of intestinal inflammatory factors in mice.
王韬 费建东 聂双发 李磊. 薏苡仁油对小鼠肠道菌群及炎症因子的影响[J]. 中国医药导报, 2020, 17(36): 31-35.
WANG Tao FEI Jiandong NIE Shuangfa LI Lei. Effect of Coicis Semen oil on intestinal flora and inflammatory factors in mice. 中国医药导报, 2020, 17(36): 31-35.
[1] 罗博文，刘芳，蒋振岳，等.薏苡仁肠道营养学的研究[J].现代食品，2019（14）：81-84.
[2] 梁镫月，李桂贤，韦德锋，等.中药调节肠道菌群在溃疡性结肠炎治疗中的应用概述[J].山东中医杂志，2020，39（2）：195-198.
[3] Araya M，Figueroa G. Resident intestinal flora. Physiological functions and changes [J]. Rev Chil Pediatr，1985，56（6）：491-497.
[4] Di S，Wang Y，Han L，et al. The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders [J]. Evid Based Complement Alternat Med，2019，2019（29）：589-620.
[5] Zuo F，Zhou ZM，Yan MZ，et al. Metabolism of constituents in Huangqin-Tang，a prescription in traditional Chinese medicine，by human intestinal flora [J]. Biol Pharm Bull，2002，25（5）：558-563.
[6] 中华人民共和国卫生部.保健食品检验与评价技术规范（2003年版）[S].北京.
[7] 吴人杰，许平翠，寿旦，等.一测多评法同时测定薏苡仁油中4种甘油三酯类抗肿瘤成分的含量[J].中国药房，2019，30（10）：1375-1380.
[8] 国家药典委员会.中华人民共和国药典[M].一部.北京：中国医药科技出版社，2015.
[9] 徐灵筠，赵琴丽，庞小燕，等.ERIC-PCR指纹图谱技术分析糖尿病小鼠肠道细菌群落变化[J].中国微生态学杂志，2007，19（4）：324-326.
[10] 张栋霞，张涛. GC/MS分析薏苡仁油组份[J].粮食与油脂，2001（1）：42-43.
[11] 陈碧莲，祝明，陈勇，等.GC-MS分析薏苡仁油中不皂化物的主要成分[J].中成药，2009，31（6）：953-954.
[12] Zhan YP，Huang XE，Cao J，et al. Clinical safety and efficacy of Kanglaite（R）（Coix Seed Oil） injection combined with chemotherapy in treating patients with gastric cancer [J]. Asian Pac J Cancer Prev，2012，13（10）：5319-5321.
[13] 杨颖，贾春丽，李志鹏，等.薏苡仁注射液联合吉西他滨对人肝癌细胞株Bel-7402增殖及凋亡的影响[J].中华全科医学，2017，15（11）：1826-1829，1855.
[14] 陈军奎，陈华海，王欣，等.肠道菌群与宿主细胞相互作用模型研究进展[J].中华预防医学杂志，2019，53（6）：638-644.
[15] 夏晶晶，于景丽，希尼尼根，等.肠道微生物组与人类癌症关系研究进展[J].微生物前沿，2018，7（1）：19-25.
[16] 郭慧玲，邵玉宇，孟和毕力格，等.肠道菌群与疾病关系的研究进展[J].微生物学通报，2015，42（2）：400-410.
[17] 黄树武，闵凡贵，王静，等.常见SPF级小鼠和大鼠肠道菌群多样性研究[J].中国实验动物学报，2019，27（2）：229-235.
[18] 王萍，郑小领，宋洁，等.胃食管反流患者肠道菌群、炎症变化及其与UCP2基因多态性的关系[J].临床和实验医学杂志，2020，19（19）：2049-2053.
[19] 黄鑫，古文鹏，黎晓慧，等.基于16S rRNA测序对树鼩肠道菌群特征与高级别肉瘤的相关性分析[J].中国比较医学杂志，2019，29（8）：11-16，49.
[20] 栾英桥，杨佳幸，陶嫦立，等.肠道菌群影响肠道细胞免疫的研究进展[J].中国免疫学杂志，2018，34（11）：1734-1737，1742.
[21] 王宏刚，姜建国，王勇.黏膜固有层T细胞及肠黏膜上皮细胞分泌的细胞因子在炎症性肠病中作用的研究进展[J].中华炎性肠病杂志，2018，2（2）：135-137.
[12] Guarner F. The intestinal flora in inflammatory bowel disease：normal or abnormal? [J]. Curr Opin Gastroenterol，2005，21（4）：414-418.
[23] Lopez-Siles M，Enrich-Capó N，Aldeguer X，et al. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects [J]. Front Cell Infect Microbiol，2018，8：281.
[24] Lopez-Siles M，Martinez-Medina M，Surís-Valls R，et al. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups Ⅰ and Ⅱ in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer [J]. Inflamm Bowel Dis，2016，22（1）：28-41.
[25] 陈琳琳，李后开.靶向肠道微生态：中药药效机理研究的新机遇与挑战[J].上海中医药杂志，2020，54（2）：14-20.
[26] 赵鑫，付志飞，高秀梅.基于肠道益生菌的中药防治疾病作用研究进展[J].世界科学技术-中医药现代化，2019， 21（6）：1097-1102.
[27] 王鑫楠，王维维，辛贵忠，等.中草药调控肠道微生态组成与代谢的研究进展[J].中医药学报，2019，47（4）：117-124.
[28] 李晓波，付瑞，王吉，等.常用实验小鼠感染诺如病毒后外周血免疫指标分析[J].中国比较医学杂志，2019，29（7）：67-75.
[29] 韩莹，张岩，杨德芳，等.真人养脏汤治疗溃疡性结肠炎的临床疗效及其对疾病活动指数评分和血清炎症因子的影响[J].临床和实验医学杂志，2019，18（9）：936-939.
[30] 盛云建，何鸿雁，宋颖，等.白介素-37抗四氯化碳诱导的小鼠肝脏炎症及机制研究[J].四川医学，2019，40（11）：1099-1105.
[31] 郭军雄，汪斌，马丽，等.p38 MAPK在腹泻型肠易激综合征大鼠中的变化及其免疫调控作用[J].中国实验动物学报，2019，27（6）：709-715.
[32] 张珣，唐莎，袁琳，等.气道上皮趋化因子与肺部炎症反应的研究进展[J].广东医学，2018，39（21）：3277-3282.
2020, Vol. 17 
京公网安备 11010502046598号